Percutaneous endoscopic gastrostomy prior to esophagectomy for esophageal cancer–a systematic review and meta-analysis

Hua Chen Fang; Musa Hassan Farah; Sheng Jie Shiue; Sheng Wei Cheng; Han Shiang Shiue; Chao Ling Cheng; Tze Sian Chan; Ai Ho Liao; Ming Shun Wu

doi:10.1080/17474124.2022.2027754

Percutaneous endoscopic gastrostomy prior to esophagectomy for esophageal cancer–a systematic review and meta-analysis

Hua Chen Fang, Musa Hassan Farah, Sheng Jie Shiue, Sheng Wei Cheng, Han Shiang Shiue, Chao Ling Cheng, Tze Sian Chan, Ai Ho Liao, Ming Shun Wu

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

Background: For resectable esophageal cancer (EC), it remains controversial whether to place percutaneous endoscopic gastrostomy (PEG) before the curative surgery to provide nutritional support during the neoadjuvant therapy. Objective: To compare surgical outcomes for patients who received preoperative PEG and those without PEG placement (No-PEG) insertion prior to surgery in a potentially operable EC. Methods: A comprehensive literature search was conducted to identify randomized and non-randomized studies comparing PEG and No-PEG groups. Results: Four retrospective studies with a total number of 1,027 patients were identified and included in this meta-analysis. The differences in anastomotic leakage, anastomotic stricture, morbidity, pulmonary complications, wound infection, and hospital stay were not statistically significant between the two groups. Operation time was significantly shorter in the PEG group. There was no PEG-related gastric conduit failure and no leak from the PEG site in the PEG group. Conclusion: We conclude preoperative PEG for resectable EC is a safe procedure with no adverse effect on the gastric tube construction and anastomosis, it can be selectively inserted for EC patients with marked weight loss and malnutrition or those at risk of developing malnutrition during neoadjuvant therapy.

Original language	English
Pages (from-to)	155-162
Number of pages	8
Journal	Expert Review of Gastroenterology and Hepatology
Volume	16
Issue number	2
DOIs	https://doi.org/10.1080/17474124.2022.2027754
Publication status	Published - Feb 2022

Keywords

esophagus cancer
neoadjuvant therapy
Percutaneous endoscopic gastrostomy
systematic review and meta-analysis

ASJC Scopus subject areas

Hepatology
Gastroenterology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1080/17474124.2022.2027754

Cite this

@article{95ae04a5f8d94f2a84aa39082f09bb7c,

title = "Percutaneous endoscopic gastrostomy prior to esophagectomy for esophageal cancer–a systematic review and meta-analysis",

abstract = "Background: For resectable esophageal cancer (EC), it remains controversial whether to place percutaneous endoscopic gastrostomy (PEG) before the curative surgery to provide nutritional support during the neoadjuvant therapy. Objective: To compare surgical outcomes for patients who received preoperative PEG and those without PEG placement (No-PEG) insertion prior to surgery in a potentially operable EC. Methods: A comprehensive literature search was conducted to identify randomized and non-randomized studies comparing PEG and No-PEG groups. Results: Four retrospective studies with a total number of 1,027 patients were identified and included in this meta-analysis. The differences in anastomotic leakage, anastomotic stricture, morbidity, pulmonary complications, wound infection, and hospital stay were not statistically significant between the two groups. Operation time was significantly shorter in the PEG group. There was no PEG-related gastric conduit failure and no leak from the PEG site in the PEG group. Conclusion: We conclude preoperative PEG for resectable EC is a safe procedure with no adverse effect on the gastric tube construction and anastomosis, it can be selectively inserted for EC patients with marked weight loss and malnutrition or those at risk of developing malnutrition during neoadjuvant therapy.",

keywords = "esophagus cancer, neoadjuvant therapy, Percutaneous endoscopic gastrostomy, systematic review and meta-analysis",

author = "Fang, {Hua Chen} and Farah, {Musa Hassan} and Shiue, {Sheng Jie} and Cheng, {Sheng Wei} and Shiue, {Han Shiang} and Cheng, {Chao Ling} and Chan, {Tze Sian} and Liao, {Ai Ho} and Wu, {Ming Shun}",

note = "Funding Information: The authors thank all the staff of the Department of Internal Medicine at Wan Fang Hospital. This work was supported by Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan, grant number 108-wf-eva-28 and 111-wf-eva-02 and Taipei Medical University-National Taiwan University of Science and Technology Joint Research Program, grant number TMU-NTUST-104-07 Funding Information: This work was supported by Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan, and National Taiwan University of Science and Technology, Taipei, Taiwan. The authors thank all the staff of the Department of Internal Medicine at Wan Fang Hospital. This work was supported by Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan, grant number 108-wf-eva-28 and 111-wf-eva-02 and Taipei Medical University-National Taiwan University of Science and Technology Joint Research Program, grant number TMU-NTUST-104-07 Funding Information: HC Fang declares the grant support by Taipei Medical University, Taipei, Taiwan, grant number 108-wf-eva-28. MS Wu declares the grant support by Taipei Medical University, Taipei, Taiwan, and National Taiwan University of Science and Technology, grant number TMU-NTUST-104-07. SJ Shiue declares the grant support by Taipei Medical University, Taipei, Taiwan, grant number 110-eva-04. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or conflict with the subject matter or materials discussed in this manuscript apart from those disclosed. Publisher Copyright: {\textcopyright} 2022 Informa UK Limited, trading as Taylor & Francis Group.",

year = "2022",

month = feb,

doi = "10.1080/17474124.2022.2027754",

language = "English",

volume = "16",

pages = "155--162",

journal = "Expert Review of Gastroenterology and Hepatology",

issn = "1747-4124",

publisher = "Taylor and Francis Ltd.",

number = "2",

}

TY - JOUR

T1 - Percutaneous endoscopic gastrostomy prior to esophagectomy for esophageal cancer–a systematic review and meta-analysis

AU - Fang, Hua Chen

AU - Farah, Musa Hassan

AU - Shiue, Sheng Jie

AU - Cheng, Sheng Wei

AU - Shiue, Han Shiang

AU - Cheng, Chao Ling

AU - Chan, Tze Sian

AU - Liao, Ai Ho

AU - Wu, Ming Shun

N1 - Funding Information: The authors thank all the staff of the Department of Internal Medicine at Wan Fang Hospital. This work was supported by Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan, grant number 108-wf-eva-28 and 111-wf-eva-02 and Taipei Medical University-National Taiwan University of Science and Technology Joint Research Program, grant number TMU-NTUST-104-07 Funding Information: This work was supported by Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan, and National Taiwan University of Science and Technology, Taipei, Taiwan. The authors thank all the staff of the Department of Internal Medicine at Wan Fang Hospital. This work was supported by Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan, grant number 108-wf-eva-28 and 111-wf-eva-02 and Taipei Medical University-National Taiwan University of Science and Technology Joint Research Program, grant number TMU-NTUST-104-07 Funding Information: HC Fang declares the grant support by Taipei Medical University, Taipei, Taiwan, grant number 108-wf-eva-28. MS Wu declares the grant support by Taipei Medical University, Taipei, Taiwan, and National Taiwan University of Science and Technology, grant number TMU-NTUST-104-07. SJ Shiue declares the grant support by Taipei Medical University, Taipei, Taiwan, grant number 110-eva-04. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or conflict with the subject matter or materials discussed in this manuscript apart from those disclosed. Publisher Copyright: © 2022 Informa UK Limited, trading as Taylor & Francis Group.

PY - 2022/2

Y1 - 2022/2

N2 - Background: For resectable esophageal cancer (EC), it remains controversial whether to place percutaneous endoscopic gastrostomy (PEG) before the curative surgery to provide nutritional support during the neoadjuvant therapy. Objective: To compare surgical outcomes for patients who received preoperative PEG and those without PEG placement (No-PEG) insertion prior to surgery in a potentially operable EC. Methods: A comprehensive literature search was conducted to identify randomized and non-randomized studies comparing PEG and No-PEG groups. Results: Four retrospective studies with a total number of 1,027 patients were identified and included in this meta-analysis. The differences in anastomotic leakage, anastomotic stricture, morbidity, pulmonary complications, wound infection, and hospital stay were not statistically significant between the two groups. Operation time was significantly shorter in the PEG group. There was no PEG-related gastric conduit failure and no leak from the PEG site in the PEG group. Conclusion: We conclude preoperative PEG for resectable EC is a safe procedure with no adverse effect on the gastric tube construction and anastomosis, it can be selectively inserted for EC patients with marked weight loss and malnutrition or those at risk of developing malnutrition during neoadjuvant therapy.

AB - Background: For resectable esophageal cancer (EC), it remains controversial whether to place percutaneous endoscopic gastrostomy (PEG) before the curative surgery to provide nutritional support during the neoadjuvant therapy. Objective: To compare surgical outcomes for patients who received preoperative PEG and those without PEG placement (No-PEG) insertion prior to surgery in a potentially operable EC. Methods: A comprehensive literature search was conducted to identify randomized and non-randomized studies comparing PEG and No-PEG groups. Results: Four retrospective studies with a total number of 1,027 patients were identified and included in this meta-analysis. The differences in anastomotic leakage, anastomotic stricture, morbidity, pulmonary complications, wound infection, and hospital stay were not statistically significant between the two groups. Operation time was significantly shorter in the PEG group. There was no PEG-related gastric conduit failure and no leak from the PEG site in the PEG group. Conclusion: We conclude preoperative PEG for resectable EC is a safe procedure with no adverse effect on the gastric tube construction and anastomosis, it can be selectively inserted for EC patients with marked weight loss and malnutrition or those at risk of developing malnutrition during neoadjuvant therapy.

KW - esophagus cancer

KW - neoadjuvant therapy

KW - Percutaneous endoscopic gastrostomy

KW - systematic review and meta-analysis

UR - http://www.scopus.com/inward/record.url?scp=85124191898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85124191898&partnerID=8YFLogxK

U2 - 10.1080/17474124.2022.2027754

DO - 10.1080/17474124.2022.2027754

M3 - Article

C2 - 35048757

AN - SCOPUS:85124191898

SN - 1747-4124

VL - 16

SP - 155

EP - 162

JO - Expert Review of Gastroenterology and Hepatology

JF - Expert Review of Gastroenterology and Hepatology

IS - 2

ER -

Percutaneous endoscopic gastrostomy prior to esophagectomy for esophageal cancer–a systematic review and meta-analysis

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint